CALCIUM‐CHANNEL BLOCKING AGENTS VERAPAMIL AND DILTIAZEM ARE INHIBITORS OF VASOPRESSIN‐INDUCED HUMAN PLATELET ACTIVATION

1. This study investigated the influences of calcium‐channel blocking agents verapamil and diltiazem on platelet responses induced by arginine vasopressin (AVP) and lysine vasopressin (LVP).

[1]  M. Trovati,et al.  EFFECT OF LABETALOL ON HUMAN PLATELET FUNCTION , 1988, Clinical and experimental pharmacology & physiology.

[2]  M. Vidaud,et al.  V1a-vasopressin specific receptors on human platelets: potentiation by ADP and epinephrine and evidence for homologous down-regulation. , 1987, Thrombosis Research.

[3]  M. Trovati,et al.  Studies on Mechanisms Involved in Hypoglycemia-Induced Platelet Activation , 1986, Diabetes.

[4]  S. Nussey,et al.  Effects of Arginine Vasopressin (AVP) Infusions on Circulating Concentrations of Platelet AVP, Factor VIII: C and von Willebrand Factor , 1986, Thrombosis and Haemostasis.

[5]  D. Macintyre,et al.  Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets. , 1986, The Biochemical journal.

[6]  J. Mehta,et al.  Calcium Blocker Diltiazem Inhibits Platelet Activation and Stimulates Vascular Prostacyclin Synthesis , 1986, The American journal of the medical sciences.

[7]  L. Kinter,et al.  Pharmacological characterization of vasopressin aggregation response of human platelets. , 1985, Thrombosis research.

[8]  P. Grant,et al.  Effects of physiological concentrations of vasopressin on haemostatic function in man. , 1985, Clinical science.

[9]  P. Uotila,et al.  Verapamil decreases the formation of thromboxane from exogenous 14C-arachidonic acid in human platelets in vitro. , 1985, Prostaglandins, leukotrienes, and medicine.

[10]  R. Blouin,et al.  Pharmacokinetics of calcium-entry blockers. , 1985, The American journal of cardiology.

[11]  N. Ardlie,et al.  Platelet activation by circulating levels of hormones: a possible link in coronary heart disease. , 1984, Thrombosis research.

[12]  J. Liard,et al.  Vasopressin in cardiovascular control: role of circulating vasopressin. , 1984, Clinical science.

[13]  T. Rink,et al.  The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin. , 1984, The Biochemical journal.

[14]  W. Frishman,et al.  The anti-platelet effects of calcium channel blockers add to their anti-anginal properties. , 1983, International journal of cardiology.

[15]  N. Ardlie,et al.  Effect of the Calcium-Entry Blocking Agent Nifedipine on Activation of Human Platelets and Comparison with Verapamil , 1983, Thrombosis and Haemostasis.

[16]  N. Ardlie,et al.  Verapamil and Collagen-Induced Platelet Reactions- Evidence for a Role for Intracellular Calcium in Platelet Activation , 1983, Thrombosis and Haemostasis.

[17]  J. Mehta,et al.  Effects of verapamil on platelet aggregation, ATP release and thromboxane generation. , 1983, Thrombosis research.

[18]  L. Edmunds,et al.  Inhibition of human platelet function by verapamil. , 1982, Thrombosis research.

[19]  G. Robertson,et al.  Arginine vasopressin response to insulin-induced hypoglycemia in man. , 1981, The Journal of clinical endocrinology and metabolism.

[20]  Y. Ikeda,et al.  Inhibition of Human Platelet Functions by Verapamil , 1981, Thrombosis and Haemostasis.

[21]  H. Johnsson.  Effects of nifedipine (Adalat) on platelet function in vitro and in vivo. , 1981, Thrombosis research.

[22]  Joan F. Zilva,et al.  Metabolic Control and Disease , 1980 .

[23]  M. Scrutton,et al.  Positive Interaction between Agonists in the Aggregation Response of Human Blood Platelets: Interaction between ADP, Adrenaline and Vasopressin , 1980, British journal of haematology.

[24]  P. Baylis,et al.  PLASMA-ARGININE-VASOPRESSIN RESPONSE TO INSULIN-INDUCED HYPOGLYCÆMIA , 1977, The Lancet.

[25]  R. Haslam,et al.  Aggregation of human blood platelets by vasopressin. , 1972, The American journal of physiology.

[26]  H. Weiss,et al.  Thrombocytopathia Due to Abnormalities in Platelet Release Reaction—Studies on Six Unrelated Patients , 1972 .

[27]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.

[28]  L. Mattiello,et al.  Arginine vasopressin release from human platelets after irreversible aggregation. , 1990, Clinical science.

[29]  L. Mattiello,et al.  Studies on inhibition of human platelet response by diltiazem. , 1990, General pharmacology.

[30]  J. Filep,et al.  Mechanism of vasopressin-induced platelet aggregation. , 1987, Thrombosis research.

[31]  P. Weber,et al.  Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets. , 1986, The Biochemical journal.

[32]  J. Reid,et al.  Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. , 1985, British journal of clinical pharmacology.

[33]  Y. Nakashima,et al.  Effects of nifedipine on platelet function. , 1985, American heart journal.